Bacterial vaginosis, the inflammatory response and the risk of preterm birth: A role for genetic epidemiology in the prevention of preterm birth

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 6, 2004, Pages 1509-1519

  Romero, Roberto ^a,b   Chaiworapongsa, Tinnakorn ^a   Kuivaniemi, Helena ^a   Tromp, Gerard ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; METRONIDAZOLE; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; DIAGNOSTIC PROCEDURE; EPIDEMIOLOGICAL DATA; GENE INTERACTION; GENETIC EPIDEMIOLOGY; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTRAUTERINE INFECTION; MOLECULAR INTERACTION; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK; SCREENING; VAGINA FLORA; VAGINITIS;

EID: 3442896520     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.01.002     Document Type: Editorial

References (149)

1. Macones G., Parry S., Elkousy M., Clothier B., Ural S.H., Strauss J.F. III. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol. 2004;1504-1508
2. Eschenbach D.A., Hillier S., Critchlow C., Stevens C., DeRouen T., Holmes K.K. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol. 158:1988;819-828
3. Spiegel C.A. Bacterial vaginosis. Clin Microbiol Rev. 4:1991;485-502
4. Eschenbach D.A., Gravett M.G., Chen K.C., Hoyme U.B., Holmes K.K. Bacterial vaginosis during pregnancy: an association with prematurity and postpartum complications. Scand J Urol Nephrol Suppl. 86:1984;213-222
5. Eschenbach D.A. Bacterial vaginosis and anaerobes in obstetric- gynecologic infection. Clin Infect Dis. 16 Suppl 4:1993;S282-S287
6. McGregor J.A., French J.I. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv. 55:2000;S1-S19
7. Ugwumadu A.H. Bacterial vaginosis in pregnancy. Curr Opin Obstet Gynecol. 14:2002;115-118
8. Sobel J.D. Bacterial vaginosis. Annu Rev Med. 51:2000;349-356
9. Gibbs R.S. Chorioamnionitis and bacterial vaginosis. Am J Obstet Gynecol. 169:1993;460-462
10. Hillier S.L., Nugent R.P., Eschenbach D.A., Krohn M.A., Gibbs R.S., Martin D.H., et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med. 333:1995;1737-1742
11. Meis P.J., Goldenberg R.L., Mercer B., Moawad A., Das A., McNellis D., et al. The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 173:1995;1231-1235
12. Goldenberg R.L., Thom E., Moawad A.H., Johnson F., Roberts J., Caritis S.N. The preterm prediction study: fetal fibronectin, bacterial vaginosis, and peripartum infection. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol. 87:1996;656-660
13. Goepfert A.R., Goldenberg R.L. Prediction of prematurity. Curr Opin Obstet Gynecol. 8:1996;417-427
14. Carey J.C., Klebanoff M.A. What have we learned about vaginal infections and preterm birth? Semin Perinatol. 27:2003;212-216
15. Flynn C.A., Helwig A.L., Meurer L.N. Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis. J Fam Pract. 48:1999;885-892
16. Riduan J.M., Hillier S.L., Utomo B., Wiknjosastro G., Linnan M., Kandun N. Bacterial vaginosis and prematurity in Indonesia: association in early and late pregnancy. Am J Obstet Gynecol. 169:1993;175-178
17. Kimberlin D.F., Andrews W.W. Bacterial vaginosis: association with adverse pregnancy outcome. Semin Perinatol. 22:1998;242-250
18. Paige D.M., Augustyn M., Adih W.K., Witter F., Chang J. Bacterial vaginosis and preterm birth: a comprehensive review of the literature. J Nurse Midwifery. 43:1998;83-89
19. Chaim W., Mazor M., Leiberman J.R. The relationship between bacterial vaginosis and preterm birth: a review. Arch Gynecol Obstet. 259:1997;51-58
20. Subtil D., Denoit V., Le Goueff F., Husson M.O., Trivier D., Puech F. The role of bacterial vaginosis in preterm labor and preterm birth: a case-control study. Eur J Obstet Gynecol Reprod Biol. 101:2002;41-46
21. Newton E.R., Piper J., Peairs W. Bacterial vaginosis and intraamniotic infection. Am J Obstet Gynecol. 176:1997;672-677
22. Martius J., Eschenbach D.A. The role of bacterial vaginosis as a cause of amniotic fluid infection, chorioamnionitis and prematurity - a review. Arch Gynecol Obstet. 247:1990;1-13
23. Silver H.M., Sperling R.S., St Clair P.J., Gibbs R.S. Evidence relating bacterial vaginosis to intraamniotic infection. Am J Obstet Gynecol. 161:1989;808-812
24. Hay P.E., Lamont R.F., Taylor-Robinson D., Morgan D.J., Ison C., Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ. 308:1994;295-298
25. Gravett M.G., Nelson H.P., DeRouen T., Critchlow C., Eschenbach D.A., Holmes K.K. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA. 256:1986;1899-1903
26. Reynolds H.D. Bacterial vaginosis and its implication in preterm labor and premature rupture of membranes: a review of the literature. J Nurse Midwifery. 36:1991;289-296
27. McGregor J.A., French J.I., Seo K. Premature rupture of membranes and bacterial vaginosis. Am J Obstet Gynecol. 169:1993;463-466
28. Lamont R.F. Recent evidence associated with the condition of preterm prelabour rupture of the membranes. Curr Opin Obstet Gynecol. 15:2003;91-99
29. Jacobsson B., Pernevi P., Chidekel L., Jorgen Platz-Christensen J. Bacterial vaginosis in early pregnancy may predispose for preterm birth and postpartum endometritis. Acta Obstet Gynecol Scand. 81:2002;1006-1010
30. Kurki T., Sivonen A., Renkonen O.V., Savia E., Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol. 79:1992;173-177
31. French J.I., McGregor J.A. Bacterial vaginosis. Faro S., Soper D.E. Infectious diseases in women. 2001;221-239 WB Saunders, Philadelphia
32. Donders G.G., Bosmans E., Dekeersmaecker A., Vereecken A., Van Bulck B., Spitz B. Pathogenesis of abnormal vaginal bacterial flora. Am J Obstet Gynecol. 182:2000;872-878
33. Hill L.V. Anaerobes and Gardnerella vaginalis in non-specific vaginitis. Genitourin Med. 61:1985;114-119
34. Blackwell A., Barlow D. Clinic diagnosis of anaerobic vaginosis (non-specific vaginitis): a practical guide. Br J Vener Dis. 58:1982;387-393
35. Steele C., Fidel P.L. Jr. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun. 70:2002;577-583
36. Sobel J.D. Vaginitis. N Engl J Med. 337:1997;1896-1903
37. Spiegel C.A., Amsel R., Holmes K.K. Diagnosis of bacterial vaginosis by direct Gram stain of vaginal fluid. J Clin Microbiol. 18:1983;170-177
38. Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol. 29:1991;297-301
39. Schwebke J.R., Hillier S.L., Sobel J.D., McGregor J.A., Sweet R.L. Validity of the vaginal Gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol. 88:1996;573-576
40. Nelson D.B., Macones G. Bacterial vaginosis in pregnancy: current findings and future directions. Epidemiol Rev. 24:2002;102-108
41. Donder G.G., Vereecken A., Bosmans E., Dekeersmaecker A., Salembier G., Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG. 109:2002;34-43
42. Hillier S.L., Martius J., Krohn M., Kiviat N., Holmes K.K., Eschenbach D.A. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med. 319:1988;972-978
43. Romero R., Sirtori M., Oyarzun E., Avila C., Mazor M., Callahan R., et al. Infection and labor: V, prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol. 161:1989;817-824
44. Gibbs R.S., Romero R., Hillier S.L., Eschenbach D.A., Sweet R.L. A review of premature birth and subclinical infection. Am J Obstet Gynecol. 166:1992;1515-1528
45. Romero R., Avila C., Sepulveda W., et al. The role of systemic and intrauterine infection in preterm labor. Fuchs A., Fuchs F., Stubblefield P. Preterm birth: causes, prevention, and management. 2nd edition:1993;97-136 McGraw-Hill, New York
46. McGregor J.A., French J.I., Witkin S. Infection and prematurity: evidence-based approaches. Curr Opin Obstet Gynecol. 8:1996;428-432
47. Andrews W.W., Hauth J.C., Goldenberg R.L. Infection and preterm birth. Am J Perinatol. 17:2000;357-365
48. Gravett M.G., Hitti J., Hess D.L., Eschenbach D.A. Intrauterine infection and preterm delivery: evidence for activation of the fetal hypothalamic- pituitary-adrenal axis. Am J Obstet Gynecol. 182:2000;1404-1413
49. Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med. 342:2000;1500-1507
50. Hitti J., Tarczy-Hornoch P., Murphy J., Hillier S.L., Aura J., Eschenbach D.A. Amniotic fluid infection, cytokines, and adverse outcome among infants at 34 weeks' gestation or less. Obstet Gynecol. 98:2001;1080-1088
51. Hillier S.L., Witkin S.S., Krohn M.A., Watts D.H., Kiviat N.B., Eschenbach D.A. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol. 81:1993;941-948
52. Romero R., Oyarzun E., Mazor M., Sirtori M., Hobbins J.C., Bracken M. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol. 73:1989;576-582
53. Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2000;CD000490
54. King J., Flenady V. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev. 2002;CD000246
55. Kenyon S.L., Taylor D.J., Tarnow-Mordi W. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. Lancet. 357:2001;989-994
56. Thorp J.M. Jr., Hartmann K.E., Berkman N.D., Carey T.S., Lohr K.N., Gavin N.I., et al. Antibiotic therapy for the treatment of preterm labor: a review of the evidence. Am J Obstet Gynecol. 186:2002;587-592
57. Romero R., Mazor M., Munoz H., Gomez R., Galasso M., Sherer D.M. The preterm labor syndrome. Ann N Y Acad Sci. 734:1994;414-429
58. Romero R., Sibai B., Caritis S., Paul R., Depp R., Rosen M., et al. Antibiotic treatment of preterm labor with intact membranes: a multicenter, randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol. 169:1993;764-774
59. Mertz H.L., Ernest J.M. Antibiotics and preterm labor. Curr Womens Health Rep. 1:2001;20-26
60. Stetzer B.P., Mercer B.M. Antibiotics and preterm labor. Clin Obstet Gynecol. 43:2000;809-817
61. Goldenberg R.L., Iams J.D., Mercer B.M., Meis P.J., Moawad A.H., Copper R.L., et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Public Health. 88:1998;233-238
62. Hill G.B. Preterm birth: associations with genital and possibly oral microflora. Ann Periodontol. 3:1998;222-232
63. Morales W.J., Schorr S., Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol. 171:1994;345-347
64. Hauth J.C., Goldenberg R.L., Andrews W.W., DuBard M.B., Copper R.L. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med. 333:1995;1732-1736
65. Carey J.C., Klebanoff M.A., Hauth J.C., Hillier S.L., Thom E.A., Ernest J.M., et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 342:2000;534-540
66. Paavonen J., Mangioni C., Martin M.A., Wajszczuk C.P. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet Gynecol. 96:2000;256-260
67. Kekki M., Kurki T., Pelkonen J., Kurkinen-Raty M., Cacciatore B., Paavonen J. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet Gynecol. 97:2001;643-648
68. Ugwumadu A., Manyonda I., Reid F., Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet. 361:2003;983-988
69. McDonald H.M., O'Loughlin J.A., Vigneswaran R., Jolley P.T., Harvey J.A., Bof A., et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. BJOG. 104:1997;1391-1397
70. Lamont D.F. Changes in vaginal flora after 2% clindamycin vaginal cream in women at high risk of preterm birth. BJOG. 110:2003;788-789
71. Rosenstein I.J., Morgan D.J., Lamont R.F., Sheehan M., Dore C.J., Hay P.E., et al. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect Dis Obstet Gynecol. 8:2000;158-165
72. Leitich H., Brunbauer M., Bodner-Adler B., Kaider A., Egarter C., Husslein P. Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am J Obstet Gynecol. 188:2003;752-758
73. Brocklehurst P., Hannah M., McDonald H. Interventions for treating bacterial vaginosis in pregnancy (Cochrane Review). Cochrane Database Syst Rev. 2002
74. Guise J.M., Mahon S.M., Aickin M., Helfand M., Peipert J.F., Westhoff C. Screening for bacterial vaginosis in pregnancy. Am J Prev Med. 20:2001;62-72
75. Klebanoff M.A., Guise J.M., Carey J.C. Treatment recommendations for bacterial vaginosis in pregnant women. Clin Infect Dis. 36:2003;1630-1631
76. US Preventive Services Task Force. Screening for bacterial vaginosis in pregnancy. Recommendations and rationale. Am J Prev Med. 20:2001;59-61
77. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep. 51:2002;1-78
78. McDonald H., Brocklehurst P., Parsons J., Vigneswaran R. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2003;CD000262
79. Koumans E.H., Markowitz L.E., Hogan V. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin Infect Dis. 35:2002;S152-S172
80. Lamont R.F. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth. BJOG. 110 Suppl 20:2003;71-75
81. Domingue P.A., Sadhu K., Costerton J.W., Bartlett K., Chow A.W. The human vagina: normal flora considered as an in situ tissue-associated, adherent bio film. Genitourin Med. 67:1991;226-231
82. Donders G.G., Odds A., Vereecken A., Van Bulck B., Caudron J., Londers L., et al. Abnormal vaginal flora in the first trimester, but not full-blown bacterial vaginosis, is associated with preterm birth. Prenat Neonat Med. 3:1998;588-593
83. Simhan H.N., Caritis S.N., Krohn M.A., Hillier S.L. Elevated vaginal pH and neutrophils are associated strongly with early spontaneous preterm birth. Am J Obstet Gynecol. 189:2003;1150-1154
84. Yudin M.H., Hillier S.L., Wiesenfeld H.C., Krohn M.A., Amortegui A.A., Sweet R.L. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol. 188:2003;318-323
85. Cauci S., Guaschino S., De Aloysio D., Driussi S., De Santo D., Penacchioni P., et al. Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod. 9:2003;53-58
86. Donders G.G., Vereecken A., Bosmans E., Spitz B. Vaginal cytokines in normal pregnancy. Am J Obstet Gynecol. 189:2003;1433-1438
87. Mattsby-Baltzer I., Platz-Christensen J.J., Hosseini N., Rosen P. IL-1beta, IL-6, TNFalpha, fetal fibronectin, and endotoxin in the lower genital tract of pregnant women with bacterial vaginosis. Acta Obstet Gynecol Scand. 77:1998;701-706
88. Imseis H.M., Greig P.C., Livengood C.H. III, Shunior E., Durda P., Erikson M. Characterization of the inflammatory cytokines in the vagina during pregnancy and labor and with bacterial vaginosis. J Soc Gynecol Investig. 4:1997;90-94
89. Balu R.B., Savitz D.A., Ananth C.V., Hartmann K.E., Miller W.C., Thorp J.M., et al. Bacterial vaginosis, vaginal fluid neutrophil defensins, and preterm birth. Obstet Gynecol. 101:2003;862-868
90. Balu R.B., Savitz D.A., Ananth C.V., Hartmann K.E., Miller W.C., Thorp J.M., et al. Bacterial vaginosis and vaginal fluid defensins during pregnancy. Am J Obstet Gynecol. 187:2002;1267-1271
91. Taylor-Robinson D., Morgan D.J., Sheehan M., Rosenstein I.J., Lamont R.F. Relation between Gram-stain and clinical criteria for diagnosing bacterial vaginosis with special reference to Gram grade II evaluation. Int J STD AIDS. 14:2003;6-10
92. Simhan H.N., Caritis S.N., Krohn M.A., Martinez D.T., Landers D.V., Hillier S.L. Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol. 189:2003;560-567
93. Yudin M.H., Landers D.V., Meyn L., Hillier S.L. Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol. 102:2003;527-534
94. Iwasaki A. The role of dendritic cells in immune responses against vaginal infection by herpes simplex virus type 2. Microbes Infect. 5:2003;1221-1230
95. Zhao X., Deak E., Soderberg K., Linehan M., Spezzano D., Zhu J., et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med. 197:2003;153-162
96. Bellingan G. Inflammatory cell activation in sepsis. Br Med Bull. 55:1999;12-29
97. Kornman K.S., di Giovine F.S. Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis. Ann Periodontol. 3:1998;327-338
98. Galbraith G.M., Steed R.B., Sanders J.J., Pandey J.P. Tumor necrosis factor alpha production by oral leukocytes: influence of tumor necrosis factor genotype. J Periodontol. 69:1998;428-433
99. Kornman K.S., Crane A., Wang H.Y., di Giovine F.S., Newman M.G., Pirk F.W., et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol. 24:1997;72-77
100. Goepfert A.R., Goldenberg R.L., Andrews W.W., Hauth J.C., Mercer B., Iams J., et al. The Preterm Prediction Study: association between cervical interleukin 6 concentration and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 184:2001;483-488
101. Sorensen T.I., Nielsen G.G., Andersen P.K., Teasdale T.W. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med. 318:1988;727-732
102. Cooke G.S., Hill A.V. Genetics of susceptibility to human infectious disease. Nat Rev Genet. 2:2001;967-977
103. Segal S., Hill A.V. Genetic susceptibility to infectious disease. Trends Microbiol. 11:2003;445-448
104. Mira J.P., Cariou A., Grall F., Delclaux C., Losser M.R., Heshmati F., et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA. 282:1999;561-568
105. Amory J.H., Hitti J., Lawler R., Eschenbach D.A. Increased tumor necrosis factor-alpha production after lipopolysaccharide stimulation of whole blood in patients with previous preterm delivery complicated by intra-amniotic infection or inflammation. Am J Obstet Gynecol. 185:2001;1064-1067
106. Romero R., Mazor M., Wu Y.K., Avila C., Oyarzun E., Mitchell M.D. Bacterial endotoxin and tumor necrosis factor stimulate prostaglandin production by human decidua. Prostaglandins Leukot Essent Fatty Acids. 37:1989;183-186
107. Romero R., Mazor M., Manogue K., Oyarzun E., Cerami A. Human decidua: a source of cachectin-tumor necrosis factor. Eur J Obstet Gynecol Reprod Biol. 41:1991;123-127
108. Casey M.L., Cox S.M., Beutler B., Milewich L., MacDonald P.C. Cachectin/tumor necrosis factor-alpha formation in human decidua: potential role of cytokines in infection-induced preterm labor. J Clin Invest. 83:1989;430-436
109. Romero R., Mazor M., Sepulveda W., Avila C., Copeland D., Williams J. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol. 166:1992;1576-1587
110. Romero R., Manogue K.R., Mitchell M.D., Wu Y.K., Oyarzun E., Hobbins J.C., et al. Infection and labor: IV, cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol. 161:1989;336-341
111. Silver RM, Lohner S, Chen CL, et al. Tumor necrosis factor-alpha mediates LPS-induced abortion: evidence from the LPS-resistant murine strain C3H/HeJ. J Soc Gynecol Investig 40th Annual Meeting 1993:P218.
112. Fidel P.L. Jr., Romero R., Wolf N., Cutright J., Ramirez M., Araneda H., et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol. 170:1994;1467-1475
113. Fidel P.L. Jr., Romero R., Cutright J., Wolf N., Gomez R., Araneda H., et al. Treatment with the interleukin-I receptor antagonist and soluble tumor necrosis factor receptor Fc fusion protein does not prevent endotoxin-induced preterm parturition in mice. J Soc Gynecol Investig. 4:1997;22-26
114. Fortunato S.J., Menon R., Lombardi S.J. Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol. 187:2002;1159-1162
115. Watari M., Watari H., DiSanto M.E., Chacko S., Shi G.P., Strauss J.F. III. Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am J Pathol. 154:1999;1755-1762
116. Athayde N., Edwin S.S., Romero R., Gomez R., Maymon E., Pacora P., et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol. 179:1998;1248-1253
117. Maymon E., Romero R., Pacora P., Gervasi M.T., Gomez R., Edwin S.S., et al. Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection. Am J Obstet Gynecol. 183:2000;887-894
118. Romero R., Chaiworapongsa T., Espinoza J., Gomez R., Yoon B.H., Edwin S., et al. Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol. 187:2002;1125-1130
119. Osmers R.G., Adelmann-Grill B.C., Rath W., Stuhlsatz H.W., Tschesche H., Kuhn W. Biochemical events in cervical ripening dilatation during pregnancy and parturition. J Obstet Gynaecol. 21:1995;185-194
120. Rath W., Winkler M., Kemp B. The importance of extracellular matrix in the induction of preterm delivery. J Perinat Med. 26:1998;437-441
121. Chwalisz K., Benson M., Scholz P., Daum J., Beier H.M., Hegele-Hartung C. Cervical ripening with the cytokines interleukin 8, interleukin 1 beta and tumour necrosis factor alpha in guinea-pigs. Hum Reprod. 9:1994;2173-2181
122. Bennett B.B., Clark P., Riley P., Hardt N.S., Duff P. The association of asymptomatic bacterial vaginosis with upper genital tract infection. Prim Care Update Ob Gyns. 5:1998;150
123. Costerton W., Veeh R., Shirtliff M., Pasmore M., Post C., Ehrlich G. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest. 112:2003;1466-1477
124. Tiret L. Gene-environment interaction: a central concept in multifactorial diseases. Proc Nutr Soc. 61:2002;457-463
125. Clayton D., McKeigue P.M. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet. 358:2001;1356-1360
126. Khoury M.J., Flanders W.D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol. 144:1996;207-213
127. Becher H., Schmidt S., Chang-Claude J. Reproductive factors and familial predisposition for breast cancer by age 50 years: a case-control-family study for assessing main effects and possible gene-environment interaction. Int J Epidemiol. 32:2003;38-48
128. Dizier M.H., Selinger-Leneman H., Genin E. Testing linkage and gene x environment interaction: comparison of different affected sib-pair methods. Genet Epidemiol. 25:2003;73-79
129. Kelada S.N., Eaton D.L., Wang S.S., Rothman N.R., Khoury M.J. The role of genetic polymorphisms in environmental health. Environ Health Perspect. 111:2003;1055-1064
130. Tait K.F., Gough S.C. The genetics of autoimmune endocrine disease. Clin Endocrinol (Oxf). 59:2003;1-11
131. Nance W.E. The genetics of deafness. Ment Retard Dev Disabil Res Rev. 9:2003;109-119
132. Albagha O.M., Ralston S.H. Genetic determinants of susceptibility to osteoporosis. Endocrinol Metab Clin North Am. 32:2003;65-81. vi
133. Allen J.K. Genetics and cardiovascular disease. Nurs Clin North Am. 35:2000;653-662
134. Rubattu S., Volpe M. Genetic basis of cerebrovascular accidents associated with hypertension. Cardiologia. 44:1999;433-437
135. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 301:2003;386-389
136. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., et al. Role of genotype in the cycle of violence in maltreated children. Science. 297:2002;851-854
137. Roberts A.K., Monzon-Bordonaba F., Van Deerlin P.G., Holder J., Macones G.A., Morgan M.A., et al. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol. 180:1999;1297-1302
138. Romero R., Kuivaniemi H., Tromp G., Olson J. The design, execution, and interpretation of genetic association studies to decipher complex diseases. Am J Obstet Gynecol. 187:2002;1299-1312
139. Dizon-Townson D.S., Major H., Varner M., Ward K. A promoter mutation that increases transcription of the tumor necrosis factor-alpha gene is not associated with preterm delivery. Am J Obstet Gynecol. 177:1997;810-813
140. Dahlman I., Eaves I.A., Kosoy R., Morrison V.A., Heward J., Gough S.C., et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet. 30:2002;149-150
141. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet. 29:2001;306-309
142. Ferrand P.E., Parry S., Sammel M., Macones G.A., Kuivaniemi H., Romero R., et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod. 8:2002;494-501
143. Fujimoto T., Parry S., Urbanek M., Sammel M., Macones G., Kuivaniemi H., et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem. 277:2002;6296-6302
144. Kalish R., Chasen S., Hunter T., Witkin S. Fetal gene polymorphisms influence pregnancy outcome in women with multiple gestations. Am J Obstet Gynecol. 187:2003;S122
145. Romero R., Gomez R., Ghezzi F., Yoon B.H., Mazor M., Edwin S.S., et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol. 179:1998;186-193
146. Gerber S., Yih M., Vardhana S., Meagher-Villemure K., Vial Y., Hohlfeld P., Witkin S. Relation between fetal interleukin-1 receptor antagonist (IL-1RA) gene polymorphism and unexplained fetal death. Am J Obstet Gynecol. 187:2003;S58
147. Gomez R., Romero R., Ghezzi F., Yoon B.H., Mazor M., Berry S.M. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 179:1998;194-202
148. Yoon B.H., Romero R., Park J.S., Kim C.J., Kim S.H., Choi J.H., et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol. 182:2000;675-681
149. Yoon B.H., Romero R., Kim K.S., Park J.S., Ki S.H., Kim B.I., et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 181:1999;773-779